193 related articles for article (PubMed ID: 11459464)
1. Avidin-dendrimer-(1B4M-Gd)(254): a tumor-targeting therapeutic agent for gadolinium neutron capture therapy of intraperitoneal disseminated tumor which can be monitored by MRI.
Kobayashi H; Kawamoto S; Saga T; Sato N; Ishimori T; Konishi J; Ono K; Togashi K; Brechbiel MW
Bioconjug Chem; 2001; 12(4):587-93. PubMed ID: 11459464
[TBL] [Abstract][Full Text] [Related]
2. Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice.
Sato N; Kobayashi H; Saga T; Nakamoto Y; Ishimori T; Togashi K; Fujibayashi Y; Konishi J; Brechbiel MW
Clin Cancer Res; 2001 Nov; 7(11):3606-12. PubMed ID: 11705883
[TBL] [Abstract][Full Text] [Related]
3. Radiolabeling of avidin with very high specific activity for internal radiation therapy of intraperitoneally disseminated tumors.
Mamede M; Saga T; Kobayashi H; Ishimori T; Higashi T; Sato N; Brechbiel MW; Konishi J
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3756-62. PubMed ID: 14506168
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer.
Kobayashi H; Sato N; Kawamoto S; Saga T; Hiraga A; Haque TL; Ishimori T; Konishi J; Togashi K; Brechbiel MW
Bioconjug Chem; 2001; 12(1):100-7. PubMed ID: 11170372
[TBL] [Abstract][Full Text] [Related]
5. Radiosynthesis, biodistribution and micro-SPECT imaging study of dendrimer-avidin conjugate.
Xu X; Zhang Y; Wang X; Guo X; Zhang X; Qi Y; Shen YM
Bioorg Med Chem; 2011 Mar; 19(5):1643-8. PubMed ID: 21310621
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW
Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971
[TBL] [Abstract][Full Text] [Related]
7. Micro-MR angiography of normal and intratumoral vessels in mice using dedicated intravascular MR contrast agents with high generation of polyamidoamine dendrimer core: reference to pharmacokinetic properties of dendrimer-based MR contrast agents.
Kobayashi H; Kawamoto S; Saga T; Sato N; Hiraga A; Konishi J; Togashi K; Brechbiel MW
J Magn Reson Imaging; 2001 Dec; 14(6):705-13. PubMed ID: 11747027
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium neutron capture therapy (GdNCT) of melanoma cells and solid tumors with the magnetic resonance imaging contrast agent Gadobutrol.
Hofmann B; Fischer CO; Lawaczeck R; Platzek J; Semmler W
Invest Radiol; 1999 Feb; 34(2):126-33. PubMed ID: 9951792
[TBL] [Abstract][Full Text] [Related]
9. Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core.
Kobayashi H; Kawamoto S; Saga T; Sato N; Hiraga A; Ishimori T; Akita Y; Mamede MH; Konishi J; Togashi K; Brechbiel MW
Magn Reson Med; 2001 Oct; 46(4):795-802. PubMed ID: 11590657
[TBL] [Abstract][Full Text] [Related]
10. Cellular uptake and in vitro antitumor efficacy of composite liposomes for neutron capture therapy.
Peters T; Grunewald C; Blaickner M; Ziegner M; Schütz C; Iffland D; Hampel G; Nawroth T; Langguth P
Radiat Oncol; 2015 Feb; 10():52. PubMed ID: 25889824
[TBL] [Abstract][Full Text] [Related]
11. Gadolinium as a neutron capture therapy agent.
Shih JL; Brugger RM
Med Phys; 1992; 19(3):733-44. PubMed ID: 1508113
[TBL] [Abstract][Full Text] [Related]
12. Hybrid Calcium Phosphate-Polymeric Micelles Incorporating Gadolinium Chelates for Imaging-Guided Gadolinium Neutron Capture Tumor Therapy.
Mi P; Dewi N; Yanagie H; Kokuryo D; Suzuki M; Sakurai Y; Li Y; Aoki I; Ono K; Takahashi H; Cabral H; Nishiyama N; Kataoka K
ACS Nano; 2015 Jun; 9(6):5913-21. PubMed ID: 26033034
[TBL] [Abstract][Full Text] [Related]
13. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
[TBL] [Abstract][Full Text] [Related]
14. Development of a Gadolinium-Boron-Conjugated Albumin for MRI-Guided Neutron Capture Therapy.
Okada S; Nishimura K; Ainaya Q; Shiraishi K; Anufriev SA; Sivaev IB; Sakurai Y; Suzuki M; Yokoyama M; Nakamura H
Mol Pharm; 2023 Dec; 20(12):6311-6318. PubMed ID: 37909734
[TBL] [Abstract][Full Text] [Related]
15. Novel intravascular macromolecular MRI contrast agent with generation-4 polyamidoamine dendrimer core: accelerated renal excretion with coinjection of lysine.
Kobayashi H; Sato N; Kawamoto S; Saga T; Hiraga A; Ishimori T; Konishi J; Togashi K; Brechbiel MW
Magn Reson Med; 2001 Sep; 46(3):457-64. PubMed ID: 11550236
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody-dendrimer conjugates enable radiolabeling of antibody with markedly high specific activity with minimal loss of immunoreactivity.
Kobayashi H; Sato N; Saga T; Nakamoto Y; Ishimori T; Toyama S; Togashi K; Konishi J; Brechbiel MW
Eur J Nucl Med; 2000 Sep; 27(9):1334-9. PubMed ID: 11007515
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of VEGFR-targeted macromolecular MRI contrast agent based on biotin-avidin-specific binding.
Liu Y; Wu X; Sun X; Wang D; Zhong Y; Jiang D; Wang T; Yu D; Zhang N
Int J Nanomedicine; 2017; 12():5039-5052. PubMed ID: 28765707
[TBL] [Abstract][Full Text] [Related]
18. Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging.
Xu H; Regino CA; Koyama Y; Hama Y; Gunn AJ; Bernardo M; Kobayashi H; Choyke PL; Brechbiel MW
Bioconjug Chem; 2007; 18(5):1474-82. PubMed ID: 17711320
[TBL] [Abstract][Full Text] [Related]
19. Positive effects of polyethylene glycol conjugation to generation-4 polyamidoamine dendrimers as macromolecular MR contrast agents.
Kobayashi H; Kawamoto S; Saga T; Sato N; Hiraga A; Ishimori T; Konishi J; Togashi K; Brechbiel MW
Magn Reson Med; 2001 Oct; 46(4):781-8. PubMed ID: 11590655
[TBL] [Abstract][Full Text] [Related]
20. Are gadolinium contrast agents suitable for gadolinium neutron capture therapy?
De Stasio G; Rajesh D; Casalbore P; Daniels MJ; Erhardt RJ; Frazer BH; Wiese LM; Richter KL; Sonderegger BR; Gilbert B; Schaub S; Cannara RJ; Crawford JF; Gilles MK; Tyliszczak T; Fowler JF; Larocca LM; Howard SP; Mercanti D; Mehta MP; Pallini R
Neurol Res; 2005 Jun; 27(4):387-98. PubMed ID: 15949236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
